Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Angewandte Chemie (International Ed. in English)|May 2, 2024
Kinase Inhibition via Small Molecule-Induced Intramolecular Protein Cross-LinkingXuan Wang, Jie Sun, Huisi Huang, et al.Biomaterials|April 10, 2013
Silica-coated superparamagnetic iron oxide nanoparticles targeting of EPCs in ischemic brain injuryQianyun Li, Guanghui Tang, Sihan Xue, et al.Stem Cells (Dayton, Ohio)|August 8, 2014
Mesenchymal stem cells maintain blood-brain barrier integrity by inhibiting aquaporin-4 upregulation after cerebral ischemiaGuanghui Tang, Yanqun Liu, Zhijun Zhang, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 2, 2015
MicroRNA-29b is a therapeutic target in cerebral ischemia associated with aquaporin 4Yang Wang, Jun Huang, Yuanyuan Ma, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|June 11, 2021
Cell-Penetrating Mitochondrion-Targeting Ligands for the Universal Delivery of Small Molecules, Proteins and NanomaterialsQicai Xiao, Wei Du, Xiao Dong, et al.Stroke|January 7, 2012
Netrin-1 hyperexpression in mouse brain promotes angiogenesis and long-term neurological recovery after transient focal ischemiaHaiyan Lu, Yongting Wang, Xiaosong He, et al.Journal of the American Chemical Society|August 20, 2024
Small Molecule-Induced Post-Translational Acetylation of Catalytic Lysine of Kinases in Mammalian CellsGuanghui Tang, Xuan Wang, Huisi Huang, et al.Angewandte Chemie (International Ed. in English)|April 19, 2022
Cell-Active, Reversible, and Irreversible Covalent Inhibitors That Selectively Target the Catalytic Lysine of BCR-ABL KinasePeng Chen, Jie Sun, Chengjun Zhu, et al.Journal of Advanced Research|September 10, 2024
Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategiesJie Sun, Liang Lou, Chengjun Zhu, et al.European Journal of Medicinal Chemistry|July 27, 2023
Cell-active, irreversible covalent inhibitors that selectively target the catalytic lysine of EGFR by using fluorosulfate-based SuFEx chemistryGuanghui Tang, Wei Wang, Xuan Wang, et al.Pageof 6